Your browser doesn't support javascript.
loading
Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone.
Cottone, Lucia; Ligammari, Lorena; Lee, Hang-Mao; Knowles, Helen J; Henderson, Stephen; Bianco, Sara; Davies, Christopher; Strauss, Sandra; Amary, Fernanda; Leite, Ana Paula; Tirabosco, Roberto; Haendler, Kristian; Schultze, Joachim L; Herrero, Javier; O'Donnell, Paul; Grigoriadis, Agamemnon E; Salomoni, Paolo; Flanagan, Adrienne M.
Affiliation
  • Cottone L; Department of Pathology, UCL Cancer Institute, University College London, London, WC1E 6BT, UK.
  • Ligammari L; Department of Pathology, UCL Cancer Institute, University College London, London, WC1E 6BT, UK.
  • Lee HM; German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany.
  • Knowles HJ; Botnar Institute for Musculoskeletal Sciences, Nuffield Department of Orthopaedics Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
  • Henderson S; Bill Lyons Informatics Centre (BLIC), UCL Cancer Institute, University College London, London, WC1E 6BT, UK.
  • Bianco S; Department of Pathology, UCL Cancer Institute, University College London, London, WC1E 6BT, UK.
  • Davies C; Samantha Dickson Brain Cancer Unit, Department of Cancer Biology, UCL Cancer Institute, University College London, London, WC1E 6BT, UK.
  • Strauss S; Department of Pathology, UCL Cancer Institute, University College London, London, WC1E 6BT, UK.
  • Amary F; Department of Histopathology, Royal National Orthopaedic Hospital, Middlesex, Stanmore, HA7 4LP, UK.
  • Leite AP; London Sarcoma Service, University College London Hospitals Foundation Trust, London, WC1E 6DD, UK.
  • Tirabosco R; Department of Histopathology, Royal National Orthopaedic Hospital, Middlesex, Stanmore, HA7 4LP, UK.
  • Haendler K; Department of Pathology, UCL Cancer Institute, University College London, London, WC1E 6BT, UK.
  • Schultze JL; Samantha Dickson Brain Cancer Unit, Department of Cancer Biology, UCL Cancer Institute, University College London, London, WC1E 6BT, UK.
  • Herrero J; Department of Histopathology, Royal National Orthopaedic Hospital, Middlesex, Stanmore, HA7 4LP, UK.
  • O'Donnell P; German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany.
  • Grigoriadis AE; Platform for Single Cell Genomics and Epigenomics (PRECISE) at the DZNE and the University of Bonn, 53127, Bonn, Germany.
  • Salomoni P; Institute of Human Genetics, University of Lübeck, Lübeck, Germany.
  • Flanagan AM; German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany.
Cell Death Differ ; 29(12): 2459-2471, 2022 12.
Article de En | MEDLINE | ID: mdl-36138226

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs osseuses / Tumeur osseuse à cellules géantes Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Cell Death Differ Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs osseuses / Tumeur osseuse à cellules géantes Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Cell Death Differ Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni